Latest Approvals News

Page 19 of 1286
Starpharma is targeting a December start for first-in-human testing of its lead DEP HER2-Lu radiopharmaceutical, subject to ethics approval, as it shifts decisively toward targeted oncology. The company also outlined stronger funding, majority ownership of Petalion’s FAP program and a proposed Chair transition at its 2026 AGM.
Ada Torres
Ada Torres
6 Nov 2026
BTC Health has expanded its exclusive ExoVasc PEARS distribution rights from Australia into India under a new five-year agreement. The opportunity is potentially significant, but Indian sales remain dependent on CDSCO import approval.
Ada Torres
Ada Torres
6 Nov 2026
ACDC Metals has begun field work at its Mount Jackson project in Nevada, with geophysics and civil works now underway ahead of a planned maiden drill campaign. The company expects to complete a 12 line-kilometre CSAMT survey and begin up to 2,500 metres of reverse circulation drilling in the fourth quarter of 2026.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Riversgold has locked in $1.55 million from sophisticated and professional investors to fund its E25/594 acquisition from Black Cat Syndicate. The deal would expand the Kalgoorlie-Northern Zone Project nearly 15-fold, but more than 258 million new shares will be issued across two tranches.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Count has completed a fully underwritten $25.0 million institutional placement to help fund its planned acquisition of a 75% interest in Skybridge Financial Group. The acquisition still requires ACCC clearance or a notification waiver before completion, targeted for Q3 FY2027.
Claire Turing
Claire Turing
6 Nov 2026
NextEra Energy has set out the preliminary financial shape of its proposed Dominion Energy acquisition, including US$62.1 billion of consideration and US$35.7 billion in goodwill. The transaction remains subject to regulatory approvals and other closing conditions, while the accounting estimates could change materially before completion.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Mayne Pharma will sell its international operations, including the Salisbury manufacturing site, to Evaris Pharma for $55.5 million in cash. The deal leaves the company focused entirely on its US Women’s Health, Dermatology and DistributeRx businesses, subject to ACCC approval.
Victor Sage
Victor Sage
6 Nov 2026
Con Edison delivered stronger third-quarter earnings and tightened its full-year adjusted EPS range, while positioning electrification and infrastructure spending as the next leg of growth. The picture is less clean beneath the headline, with year-to-date GAAP profit boosted by a Mountain Valley Pipeline sale and further equity issuance still ahead.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Hammer Metals has set 13 November for the Federal Court to consider approval of Austral Resources Australia’s proposed acquisition of the company. The hearing comes after shareholders are due to vote on the scheme and a linked demerger on 9 November.
Maxwell Dee
Maxwell Dee
6 Nov 2026
American Water and Essential Utilities have reached a settlement with all parties in a New Jersey regulatory proceeding over their proposed merger. The agreement still requires approval from the New Jersey Board of Public Utilities, and its substantive terms have not been disclosed in the filing.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Ameren has raised its 2026 earnings guidance and set a 2027 target after third-quarter adjusted EPS rose 12% year on year. The US utility also outlined a US$38.1 billion infrastructure programme supporting projected rate-base growth through 2031.
Maxwell Dee
Maxwell Dee
6 Nov 2026
AVITA Medical has raised its 2026 revenue guidance for a second time after third-quarter revenue climbed 53% year on year. The company also drew a further US$10 million under its credit facility and removed its going-concern qualification, although it remains loss-making and highly leveraged.
Victor Sage
Victor Sage
6 Nov 2026

Browse the archive

Full archive